This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Review

. 1992 Dec;6(6):437-45.

Cost effective analyses in the treatment of high blood pressure

A Fletcher¹

Affiliations

PMID: 1296007

Review

Cost effective analyses in the treatment of high blood pressure

A Fletcher. J Hum Hypertens. 1992 Dec.

. 1992 Dec;6(6):437-45.

Author

A Fletcher¹

Affiliation

¹ Department of Epidemiology and Population Sciences, London School of Hygiene and Tropical Medicine, UK.

PMID: 1296007

No abstract available

PubMed Disclaimer

Similar articles

[Ambulatory blood pressure monitoring: cost-effectiveness].
Marco JE. Marco JE. Nefrologia. 2002;22 Suppl 3:7-11. Nefrologia. 2002. PMID: 12014306 Spanish. No abstract available.
A retrospective analysis comparing the costs and cost effectiveness of amlodipine and enalapril in the treatment of hypertension.
Doyle J, Omvik P, Arikian S, Casciano J, Casciano R, Gonzalez MA, Arocho R. Doyle J, et al. Manag Care Interface. 2001 Mar;14(3):82-7. Manag Care Interface. 2001. PMID: 11301961 Clinical Trial.
[Cost-effectiveness of treatment of high blood pressure with losartan in Denmark].
Keiding H, Hildebrandt P, Burke T, Carides GW. Keiding H, et al. Ugeskr Laeger. 2006 Oct 16;168(42):3623-6. Ugeskr Laeger. 2006. PMID: 17069726 Danish.
Cost of hypertension treatment and the price of health.
Menard J, Cornu P, Day M. Menard J, et al. J Hum Hypertens. 1992 Dec;6(6):447-58. J Hum Hypertens. 1992. PMID: 1296008 Review. No abstract available.
Geriatric hypertension therapy: a guide to cost-effectiveness.
Wright JT Jr. Wright JT Jr. Geriatrics. 1988 Aug;43(8):55-62. Geriatrics. 1988. PMID: 3136056 Review.

See all similar articles

Cited by

Metoprolol: a pharmacoeconomic and quality-of-life evaluation of its use in hypertension, post-myocardial infarction and dilated cardiomyopathy.
Peters DH, Benfield P. Peters DH, et al. Pharmacoeconomics. 1994 Oct;6(4):370-400. doi: 10.2165/00019053-199406040-00004. Pharmacoeconomics. 1994. PMID: 10147474 Review.
An economic analysis of the Survival and Ventricular Enlargement (SAVE) Study. Application to the United Kingdom.
Hummel S, Piercy J, Wright R, Davie A, Bagust A, McMurray J. Hummel S, et al. Pharmacoeconomics. 1997 Aug;12(2 Pt 1):182-92. doi: 10.2165/00019053-199712020-00008. Pharmacoeconomics. 1997. PMID: 10169670 Clinical Trial.
Pharmacoeconomics of antihypertensive drug treatment: an analysis of how long patients remain on various antihypertensive therapies.
Degli Esposti L, Di Martino M, Saragoni S, Sgreccia A, Capone A, Buda S, Esposti ED. Degli Esposti L, et al. J Clin Hypertens (Greenwich). 2004 Feb;6(2):76-84. doi: 10.1111/j.1524-6175.2004.03044.x. J Clin Hypertens (Greenwich). 2004. PMID: 14872145 Free PMC article.
Economics of hypertension control. World Hypertension League.
[No authors listed] [No authors listed] Bull World Health Organ. 1995;73(4):417-24. Bull World Health Organ. 1995. PMID: 7554012 Free PMC article. Review.
Pharmacoeconomic burden of undertreating hypertension.
Degli Esposti L, Valpiani G. Degli Esposti L, et al. Pharmacoeconomics. 2004;22(14):907-28. doi: 10.2165/00019053-200422140-00002. Pharmacoeconomics. 2004. PMID: 15362928 Review.

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions

LinkOut - more resources

Medical
- MedlinePlus Health Information